Rite Aid Corporation, a prominent American drugstore chain, is contemplating shuttering 400 to 500 outlets amidst bankruptcy deliberations. While talks are ongoing, the company's massive $3.3 billion debt looms large. Concurrently, federal lawsuits and a DOJ action over alleged mishandling of opioid prescriptions challenge the pharmacy's operations.
Currently, Rite Aid is negotiating the terms of a bankruptcy plan, which may result in the permanent closure of its stores, now numbering more than 2,100 in the 17 U.S. states. It was reported that some individuals familiar with the ongoing talks with creditors told the Wall Street Journal that the company suggested closing up to 500 pharmacies in bankruptcy.
It was also said that Rite Aid also proposed to either sell or allow creditors to take over the remaining drug stores. As per Fox Business, there is one group of bondholders that prefers to liquidate a greater number of stores, and officials are said to be discussing the exact number.
But while there is an ongoing talk, Rite Aid said they have not yet made any decision. It was already reported that the drugstore chain is planning to file for bankruptcy protection due to the more than $3.3 billion debt it has incurred. It also faces thousands of federal lawsuits about its alleged part in the sweeping spread of opioids.
Washington Examiner reported that Rite Aid is also being confronted by huge pressure from the U.S. Department of Justice, which filed a lawsuit against the company for allegedly "knowingly" filling up unlawful prescriptions for controlled substances. The DOJ said the pharmacy giant missed "obvious red flags" that the medications it sold were being abused by customers such as medical fentanyl and oxycodone.
Rite Aid disagreed with how the government described its handling of opioid medications. It also denied the claims it is filling illegal prescriptions.
Photo by: Chance Pereira/Flickr(CC BY-SA 2.0)


South Korea's Exports Hit Record High in March on AI-Driven Chip Demand
Trump Claims Iran Sought Ceasefire as Middle East War Escalates
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Oil Prices Surge Over $5 as Trump Vows to Continue Iran Strikes
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Asian Currencies Weaken as Dollar Rebounds Amid Middle East Escalation
Asian Stocks Mixed in March 2026 Amid Iran War Fears and Tech Selloff
U.S. Dollar Posts Strong Monthly Gain Amid Middle East Conflict Despite Late Dip
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Asian Stocks Surge on Trump's Iran War Comments and Dip-Buying
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
South Korea's Inflation Rises Modestly in March Amid Oil Price Pressures
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments 



